Mayes Patrick A — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Mayes Patrick A has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Patrick A. Mayes is the Executive Vice President and Chief Scientific Officer at Incyte Corporation, a biopharmaceutical company focused on the development of small-molecule drugs. He has been involved in the company's research and development efforts, particularly in oncology and hematology.

Board memberships

• Incyte Corporation

Awards & honors

• Leadership in drug development at Incyte
• Contributions to oncology research
• Oversight of scientific strategy

Recent Transactions

Companies — Last 90 Days

• INCYTE CORP (INCY) — 1 filings, last 2026-07-07

Frequently Asked Questions

Who is Mayes Patrick A?

Patrick A. Mayes is the Executive Vice President and Chief Scientific Officer at Incyte Corporation, a biopharmaceutical company focused on the development of small-molecule drugs. He has been involved in the company's research and development efforts, particularly in oncology and hematology.…

How many SEC Form 4 filings has Mayes Patrick A submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Mayes Patrick A's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week